Regular Article

British Journal of Cancer (2000) 82, 1035–1040. doi:10.1054/bjoc.1999.1039 www.bjcancer.com
Published online 3 February 2000

Decreased GTPase activity of K- ras mutants deriving from human functional adrenocortical tumours

S-R Lin2, C-H Hsu2, J-H Tsai1, J-Y Wang2, T-J Hsieh2 and C-H Wu2

  1. 1Department of Internal Medicine, Kaohsiung Medical College, No 100, Shih-Chuan 1st Rd, Kaohsiung, 80317, Taiwan
  2. 2Department of Clinical Pathology, Kaohsiung Medical College, No 100, Shih-Chuan 1st Rd, Kaohsiung, 80317, Taiwan

Received 7 July 1999; Revised 7 October 1999; Accepted 18 October 1999.

Top

Abstract

Our previous studies have shown that seven out of 15 patients with adrenocortical tumours contained K- ras gene mutation. In addition, the mutation type was a multiple-site mutation, and the hot spots were located at codons 15, 16, 18 and 31, which were different from those reported before (codons 12, 13 and 61). To understand whether the mutation hot spots in human adrenocortical tumours were associated with activation of K- Ras oncogene and the alterations of its biocharacteristics, mutant K- Ras genes were cloned from tumour tissues and then constructed with expression vector pBKCMV. Mutant K- Ras genes were expressed at high levels in Escherichia coli and the resultant K- Ras proteins were shown to be functional with respect to their well-known specific, high-affinity, GDP/GTP binding. The purified K- Ras protein from E. coli were then measured for their intrinsic GTPase activity and the GTPase activity in the presence of GTPase-activating protein for Ras. The results showed that the wild-type cellular K- Ras protein (p21BN) exhibits about ten times higher intrinsic GTPase activity than the activated protein (p21BM3) encoded by mutant K- Ras gene, which mutated at codon 60. With regards to the codon 15, 16, 18 and 31 mutant K- Ras proteins (p21BM2), the GTPase activity in the presence of GAP is much lower than that of the normal K- Ras protein, whereas the intrinsic GTPase activity is nearly the same as that of the normal K- Ras protein. These results indicated that mutations at these hot spots of K- Ras gene were indeed activated K- Ras oncogene in adrenocortical tumours; however, their association with tumors needs further experiments to prove. © 2000 Cancer Research Campaign

Keywords:

GTPase, K-ras mutants, functional adrenocortical tumours

Top

References

  1. Adari H, Lowy DR, Willumsen BM, Der CJ and McCormick F (1988) Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain. Science 240: 518–521 | Article | PubMed | ISI | ChemPort |
  2. Ahmadian MR, Wiesmuller L, Lautwein A, Bischoff FR and Wittinghofer A (1996) Structural differences in the minimal catalytic domains of the GTPase-activating proteins p120GAP and neurofibromin. J Biol Chem 271: 16409–16415 | Article | PubMed | ISI | ChemPort |
  3. Anker P, Lefort F, Vasioukhin V, Lyautey J, Lederrey C, Chen XQ, Stroun M, Mulcahy HE and Farthing MJ (1997) K- ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology 112: 1114–1120 | PubMed | ChemPort |
  4. Barbacid M (1987) Ras gene. Ann Rev Biochem 56: 779–827 | Article | PubMed | ISI | ChemPort |
  5. Boriack-Sjodin PA, Margarit SM, Bar-Sagi D and Kuriyan J (1998) The structural basis of the activation of Ras by Sos [see comments]. Nature 394: 337–343 | Article | PubMed | ISI | ChemPort |
  6. Caduff RF, Svoboda-Newman SM, Ferguson AW, Johnston CM and Frank TS (1999) Comparison of mutations of Ki-Ras and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors. Am J Surg Pathol 23: 323–328 | Article | PubMed | ISI | ChemPort |
  7. Capon DJ, Seeburg PH, McGrath JP, Hayflick JS, Edman U, Levinson AD and Goeddel DV (1983) Activation of Ki- ras 2 gene in human colon and lung carcinomas by two different point mutations. Nature 304: 507–513 | Article | PubMed | ISI | ChemPort |
  8. Chen Q, Lin TH, Der CJ and Juliano RL (1996) Integrin-mediated activation of MEK and mitogen-activated protein kinase is independent of Ras. (Published erratum appears in J Biol Chem 1996 271: 22280.). J Biol Chem 271: 18122–18127 | Article | PubMed | ISI | ChemPort |
  9. Downward J (1996) Control of ras activation. Cancer Surv 27: 87–100 | PubMed | ISI | ChemPort |
  10. Feliciello A, Giuliano P, Porcellini A, Garbi C, Obici S, Mele E, Angotti E, Grieco D, Amabile G, Cassano S, Li Y, Musti AM, Rubin CS, Gottesman ME and Avvedimento EV (1996) The v-Ki- Ras oncogene alters cAMP nuclear signaling by regulating the location and the expression of cAMP-dependent protein kinase II beta. J Biol Chem 271: 25350–25359
  11. Gao HG, Chen JK, Stewart J, Song B, Rayappa C, Whong WZ and Ong T (1997) Distribution of p53 and K- ras mutations in human lung cancer tissues. Carcinogenesis 18: 473–478
  12. Grendys EC Jr, Barnes WA, Weitzel J, Sparkowski J and Schlegel R (1997) Identification of H-, K-, and N- ras point mutations in stage IB cervical carcinoma. Gynecol Oncol 65: 343–347 | Article | PubMed | ISI | ChemPort |
  13. Gross M, Sweet RW, Sathe G, Yokoyama S, Fasano O, Goldfarb M, Wigler M and Rosenberg M (1985) Purification and characterization of human H-Ras proteins expressed in Escherichia coli. Mol Cell Biol 5: 1015–1024 | PubMed | ISI | ChemPort |
  14. Guan KL and Dixon JE (1991) Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal Biochem 192: 262–267 | Article | PubMed | ISI | ChemPort |
  15. Hattori S, Maekawa M and Nakamura S (1992) Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21. Oncogene 7: 481–485 | PubMed | ISI | ChemPort |
  16. Hughes PE, Renshaw MW, Pfaff M, Forsyth J, Keivens VM, Schwartz MA and Ginsberg MH (1997) Suppression of integrin activation: a novel function of a Ras/Raf-initiated MAP kinase pathway. Cell 88: 521–530 | Article | PubMed | ISI | ChemPort |
  17. Lautenberger JA, Ulsh L, Shih TY and Papas TS (1983) High level expression in Escherichia coli of enzymatically active Harvey murine sarcoma virus p21Ras protein. Science 221: 858–860 | PubMed | ISI | ChemPort |
  18. Leitner JW, Kline T, Carel K, Goalstone M and Draznin B (1997) Hyperinsulinemia potentiates activation of p21Ras by growth factors. Endocrinology 138: 2211–2214 | Article | PubMed | ChemPort |
  19. Leon J, Guerrero I and Pellicer A (1987) Differential expression of the ras gene family in mice. Mol Cell Biol 7: 1535–1540 | PubMed | ISI | ChemPort |
  20. Lim HH, Michael GJ, Smith P, Lim L and Hall C (1992) Developmental regulation and neuronal expression of the mRNA of rat n-chimaerin, a p21rac GAP:cDNA sequence. Biochem J 287: 415–422
  21. Lim L, Manser E, Leung T and Hall C (1996) Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation segralling pathways. Eur J Biochem 242: 171–185 | Article | PubMed | ISI | ChemPort |
  22. Lin SR, Tsai JH, Yang YC and Lee SC (1998) Mutations of K- ras oncogene in human adrenal tumors in Taiwan. Br J Cancer 77: 1060–1065 | PubMed |
  23. Lin SR, Hsu CH, Tsai JH and Wang JY (1999). Effect of K- ras mutant derived from human primary aldosteronism on normal adrenocortical cells,
  24. Martin GA, Viskochil D, Bollag G, McCabe PC, Crosier WJ, Haubruck H, Conroy L, Clark R, O'Connell P and Cawthon RM (1990) The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63: 843–849 | Article | PubMed | ISI | ChemPort |
  25. Miao W, Eichelberger L, Baker L and Marshall MS (1996) p120 Ras GTPase-activating protein interacts with Ras-GTP through specific conserved residues. J Biol Chem 271: 15322–15322 | Article | PubMed | ISI | ChemPort |
  26. Molloy DP, Owen D and Grand RJ (1995) Ras binding to a C-terminal region of GAP. FEBS Lett 368: 297–303
  27. Mulcahy HE, Lyautey J, Lederrey C, Chen X, Anker P, Alstead EM, Ballinger A, Farthing MJ and Stroun M (1998) A prospective study of K- ras mutations in the plasma of pancreatic cancer patients. Clin Cancer Res 4: 271–275 | PubMed | ISI | ChemPort |
  28. Nur-E-Kamal MS and Maruta H (1992) The role of Gln61 and Glu63 of Ras GTPases in their activation by NF1 and Ras GAP. Mol Biol Cell 3: 1437–1442 | PubMed | ChemPort |
  29. Overbeck AF, Brtva TR, Cox AD, Graham SM, Huff SY, Khosravi-Far R, Quilliam LA, Solski PA and Der CJ (1995) Guanine nucleotide exchange factors: activators of Ras superfamily proteins. Mol Reprod Dev 42: 468–476 | Article | PubMed | ISI | ChemPort |
  30. Pells S, Divjak M, Romanowski P, Impey H, Hawkins NJ, Clarke AR, Hooper ML and Williamson DJ (1997) Developmentally-regulated expression of murine K- ras isoforms. Oncogene 15: 1781–1786 | Article | PubMed | ISI | ChemPort |
  31. Porras A and Santos E (1996) The insulin/Ras pathway of adipocytic differentiation of 3T3 L1 cells: dissociation between Raf-1 kinase and the MAPK/RSK cascade. Int J Obes Relat Metab Disord 20: S43–51
  32. Powers S, O'Neill K and Wigler M (1989) Dominant yeast and mammalian Ras mutations that interfere with the CD23-dependent activation of wild-type RAS in Saccharomyces cerevisiae. Mol Cell Biol 9: 390–395 | PubMed | ISI | ChemPort |
  33. Santos E and Nebreda AR (1989) Structural and functional properties of ras proteins. FASEB J 3: 2151–2163 | PubMed |
  34. Segal M, Willumsen BM and Levitzki A (1993) Residues crucial for Ras interaction with GDP-GTP exchangers. Proc Natl Acad Sci USA 90: 5564–5568 | PubMed | ChemPort |
  35. Shirozu M, Fujita-Yoshigaki J, Ito Y, Koide H, Nishimura S and Yokoyama S (1992) A glutamic acid residues at position 31 of Ras protein is essential to the signal transduction for neurite outgrowth of PC12 cells and the stimulation of GTPase activity by GAPRas. Oncogene 7: 475–480 | PubMed | ISI | ChemPort |
  36. Slamon DJ and Cline MJ (1984) Expression of cellular oncogenes binding embryonic and fetal development of the mouse. Proc Natl Acad Sci USA, 7141–7145 | Article | PubMed | ChemPort |
  37. Sung YJ, Carter M, Zhong JM and Hwang YW (1995) Mutagenesis of the H- Ras p21 at glycine-60 residue disrupts GTP-induced conformational change. Biochemistry 34: 3470–3477
  38. Vogel US, Dixon RAF, Schaber MD, Diehl RE, Marshall MS, Scolnick EM, Signal IS and Gibbs JB (1988) Cloning of bovine GAP and its interaction with oncogenic ras p21. Nature 335: 90–93 | Article | PubMed | ISI | ChemPort |
  39. Winston LA and Hunter T (1995) JAK2, Ras, and Raf are required for activation of extracellular signal-regulated kinase/mitogen-activated protein kinase by growth hormone. J Biol Chem 270: 30837–30840 | Article | PubMed | ISI | ChemPort |
  40. Wittinghofer A, Scheffzek K and Ahmadian MR (1997) The interaction of Ras with GTPase-activating proteins. FEBS Lett 410: 63–67 | Article | PubMed | ISI | ChemPort |
  41. Xu GF, Lin B, Tanaka K, Dunn D, Wood D, Gesteland R, White R, Weiss R and Tamanoi F (1990) The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 63: 835–841 | Article | PubMed | ISI | ChemPort |
  42. Yamashita N, Minamoto T, Ochiai A, Onda M and Esumi H (1995) Frequent and characteristic K-ras activation in aberrant crypt foci of colon. Is there preference among K- ras mutants for malignant progression? Cancer 75: 1527–1533 | PubMed | ISI | ChemPort |